699
Views
229
CrossRef citations to date
0
Altmetric
Original Research

Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications

, , , , &
Pages 1841-1850 | Published online: 11 Apr 2012

References

  • Montesano-GesualdiNChiricoGCataneseMTPirozziGEspositoFAROS-29 is involved in adaptive response to oxidative stressFree Radic Res200640546747616551573
  • BlackHSde GruijlFRForbesPDPhotocarcinogenesis: an overviewJ Photochem Photobiol B199740129479301042
  • HueiRNetaPChemistry of reactive oxygen speciesGilbertDLColtonCAReactive oxygen species in biological systems: An interdisciplinary approachNew YorkSpringer20023373
  • PortugalMBarakVGinsburgIKohenRInterplay among oxidants, antioxidants, and cytokines in skin disorders: present status and future considerationsBiomed Pharmacother200761741242217604942
  • Scharffetter-KochanekKWlaschekMBrenneisenPSchauenMBlaudschunRWenkJUV-induced reactive oxygen species in photocarcinogenesis and photoagingBiol Chem199737811124712579426184
  • TrenamCWBlakeDRMorrisCJSkin inflammation: reactive oxygen species and the role of ironJ Invest Dermatol19929966756821469283
  • AfaqFAdhamiVMAhmadNPrevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless miceToxicol Appl Pharmacol20031861283712583990
  • van GinkelPRSareenDSubramanianLResveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondriaClin Cancer Res200713175162516917785572
  • MehnertWMäderKSolid lipid nanoparticles: production, characterization and applicationsAdv Drug Deliv Rev2001472–316519611311991
  • MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
  • JenningVGohlaSHEncapsulation of retinoids in solid lipid nano-particles (SLN)J Microencapsul200118214915811253932
  • WissingSAMüllerRHMantheiLMayerCStructural characterization of Q10-loaded solid lipid nanoparticles by NMR spectroscopyPharm Res200421340040515070088
  • MüllerRHRungeSRavelliVMehnertWThunemannAFSoutoEBOral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystalsInt J Pharm20063171828916580159
  • KüchlerSWolfNBHeilmannS3D-wound healing model: influence of morphine and solid lipid nanoparticlesJ Biotechnol20101481243020138929
  • DinglerABlumRPNiehusHMüllerRHGohlaSSolid lipid nano-particles (SLN/Lipopearls) – a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal productsJ Microencapsul199916675176710575627
  • PugliaCFilosaRPedutoAEvaluation of alternative strategies to optimize ketorolac transdermal deliveryAAPS Pharm Sci Technol20067364
  • SoutoEBWissingSABarbosaCMMüllerRHDevelopment of a controlled release formulation based on SLN and NLC for topical clotrimazole deliveryInt J Pharm20042781717715158950
  • TeeranachaideekulVMüllerRHJunyaprasertVBEncapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC) – effects of formulation parameters on physicochemical stabilityInt J Pharm20073401–219820617482778
  • PardeikeJHommossAMüllerRHLipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal productsInt J Pharm20093661–217018418992314
  • TeskacKKristlJThe evidence for solid lipid nanoparticles mediated cell uptake of resveratrolInt J Pharm20103901616919833178
  • GokceEHSandriGBonferoniMCCyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicityInt J Pharm20083641768618725276
  • JangJHSurhYJProtective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cellsMutation Res20014961–218119011551494
  • AfzalMMatsugoBAoyamaKTakeuchiTMethod to overcome photoreaction, a serious drawback to the use of dichlorofluorescin in evaluation of reactive oxygen speciesBiochem Biophys Res Commun2003304461962412727198
  • ŠenyiğitTSonvicoFBarbieriSÖzerÖSantiPColomboPLecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skinJ Control Rel20101423368673
  • TimmsREFractional crystallization – the fat modification process for the 21st centuryEur J Lipid Sci Technol20051074857
  • IllingworthDFractionation of fatsMarangoniAGNarineSSPhysical Properties of LipidsNew YorkMarcel Dekker2002411477
  • JenningVThünemannAFGohlaSHCharacterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipidsInt J Pharm2000199216717710802410
  • UnerMYenerGImportance of solid lipid nanoparticles (SLN) in various administration routes and future perspectivesInt J Nanomedicine20072328930018019829
  • KaurIPKapilaMAgrawalRRole of novel delivery systems in developing topical antioxidants as therapeutics to combat photoageingAgeing Res Rev20076427128817933593
  • SoutoEBMullerRHNanoparticulate drug delivery systemsInforma Healthcare U S A, Inc2007166213234
  • TrombinoSCassanoRMuzzalupoRPingitoreACioneEPicciNStearyl ferulate-based solid lipid nanoparticles for the encapsulation and stabilization of beta-carotene and alfa-tocopherolColloids Surf B Biointerfaces200972218118719410436
  • RuktanonchaiUBejraphaPSakulkhuUPhysicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acidAAPS Pharm Sci Tech2009101227234
  • CullisPRChonnASempleSCInteractions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivoAdv Drug Delivery Rev1998321–2317
  • HayesMEDrummondDCHongKIncreased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylationMol Pharm2006367263617140260
  • WesołowskaOKuzdzałMStrancarJMichalakKInteraction of the chemopreventive agent resveratrol and its metabolite, piceatannol, with model membranesBiochim Biophys Acta2009178891851186019527681